EX-4.2
from 8-K
51 pages
Watson Pharmaceuticals, Inc., as Issuer and Wells Fargo Bank, National Association, as Trustee Third Supplemental Indenture Dated as of October 2, 2012 to the Indenture Dated as of August 24, 2009 1.875% Senior Notes Due 2017 3.250% Senior Notes Due 2022 4.625% Senior Notes Due 2042
12/34/56
EX-4.1
from 8-K
89 pages
Watson Pharmaceuticals, Inc., as the Company and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of August 24, 2009 Senior Debt Securities Certain Sections of This Indenture Relating to Sections 310 Through 318, Inclusive, of the Trust Indenture ACT of 1939
12/34/56
EX-4.3
from S-3ASR
88 pages
Watson Pharmaceuticals, Inc., as the Company and Wells Fargo Bank, National Association, as Trustee Indenture Dated as of [ ], 2009 Senior Debt Securities ............................... Certain Sections of This Indenture Relating to Sections 310 Through 318, Inclusive, of the Trust Indenture ACT of 1939
12/34/56
EX-4.1
from 10-Q
11 pages
This Guaranty (“Guaranty”) Is Made as of the Day of , 2003, by Each Party Set Forth in Schedule I Attached Hereto (Each, a “Guarantor”), in Favor of Wachovia Bank, National Association, a National Banking Association, as Trustee for the Holders (The “Trustee”). Unless Otherwise Defined Herein, Capitalized Terms Used Herein Shall Have the Meanings Ascribed to Them in the Indenture (As Defined Below)
12/34/56
